Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Csnk1g3 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA] | CTD | PMID:31150632 | Csnk1g3 | Rat | 1,2-dichloroethane | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28189721 and PMID:28960355 | Csnk1g3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | Csnk1g3 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | Csnk1g3 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:17942748 | Csnk1g3 | Rat | 17beta-estradiol | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Estradiol results in increased expression of CSNK1G3 mRNA | CTD | PMID:25210133 | Csnk1g3 | Rat | 17beta-estradiol | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of CSNK1G3 mRNA] | CTD | PMID:25210133 | Csnk1g3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:17942748 | Csnk1g3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33387578 | Csnk1g3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSNK1G3 mRNA | CTD | PMID:21570461 | Csnk1g3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CSNK1G3 mRNA | CTD | PMID:21354282 | Csnk1g3 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of CSNK1G3 mRNA | CTD | PMID:21346803 | Csnk1g3 | Rat | 2-bromohexadecanoic acid | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein] | CTD | PMID:38195004 | Csnk1g3 | Rat | 2-ethoxyethanol | increases expression | EXP | | 6480464 | 2-ethoxyethanol results in increased expression of CSNK1G3 mRNA | CTD | PMID:19643169 | Csnk1g3 | Rat | 2-methylcholine | affects expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of CSNK1G3 mRNA | CTD | PMID:21179406 | Csnk1g3 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:20188158 | Csnk1g3 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | Csnk1g3 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Fenretinide results in increased expression of CSNK1G3 mRNA | CTD | PMID:28973697 | Csnk1g3 | Rat | 5-aza-2'-deoxycytidine | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Decitabine results in decreased expression of CSNK1G3 mRNA | CTD | PMID:27915011 | Csnk1g3 | Rat | 5-aza-2'-deoxycytidine | decreases methylation | ISO | Csnk1g3 (Mus musculus) | 6480464 | Decitabine results in decreased methylation of CSNK1G3 gene | CTD | PMID:27923600 | Csnk1g3 | Rat | acrolein | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:32699268 | Csnk1g3 | Rat | alpha-pinene | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:32699268 | Csnk1g3 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CSNK1G3 mRNA | CTD | PMID:16483693 | Csnk1g3 | Rat | aristolochic acid A | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33212167 | Csnk1g3 | Rat | arsenite(3-) | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CSNK1G3 mRNA] | CTD | PMID:32406909 | Csnk1g3 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | Csnk1g3 | Rat | bisphenol A | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of CSNK1G3 protein | CTD | PMID:33376534 | Csnk1g3 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | Csnk1g3 | Rat | bisphenol A | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CSNK1G3 mRNA | CTD | PMID:33221593 and PMID:38074096 | Csnk1g3 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:36041667 | Csnk1g3 | Rat | cadmium atom | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein | CTD | PMID:38195004 | Csnk1g3 | Rat | cadmium atom | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:37325564 | Csnk1g3 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:21297351 | Csnk1g3 | Rat | cadmium dichloride | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSNK1G3 mRNA | CTD | PMID:37325564 | Csnk1g3 | Rat | cadmium dichloride | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CSNK1G3 protein | CTD | PMID:38195004 | Csnk1g3 | Rat | caffeine | decreases phosphorylation | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of CSNK1G3 protein | CTD | PMID:35688186 | Csnk1g3 | Rat | calcium atom | affects expression | EXP | | 6480464 | Calcium affects the expression of CSNK1G3 mRNA | CTD | PMID:15913539 | Csnk1g3 | Rat | calcium(0) | affects expression | EXP | | 6480464 | Calcium affects the expression of CSNK1G3 mRNA | CTD | PMID:15913539 | Csnk1g3 | Rat | CGP 52608 | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CSNK1G3 gene] | CTD | PMID:28238834 | Csnk1g3 | Rat | copper(II) sulfate | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CSNK1G3 mRNA | CTD | PMID:19549813 | Csnk1g3 | Rat | coumestrol | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of CSNK1G3 mRNA | CTD | PMID:19167446 | Csnk1g3 | Rat | cyclosporin A | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CSNK1G3 mRNA | CTD | PMID:25562108 | Csnk1g3 | Rat | Dibutyl phosphate | affects expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CSNK1G3 mRNA | CTD | PMID:37042841 | Csnk1g3 | Rat | dicrotophos | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28302478 | Csnk1g3 | Rat | doxorubicin | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CSNK1G3 mRNA | CTD | PMID:29803840 | Csnk1g3 | Rat | epoxiconazole | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CSNK1G3 mRNA | CTD | PMID:35436446 | Csnk1g3 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of CSNK1G3 mRNA | CTD | PMID:30307764 | Csnk1g3 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CSNK1G3 mRNA | CTD | PMID:24136188 | Csnk1g3 | Rat | folic acid | multiple interactions | ISO | Csnk1g3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:22206623 | Csnk1g3 | Rat | FR900359 | increases phosphorylation | ISO | CSNK1G3 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CSNK1G3 protein | CTD | PMID:37730182 | Csnk1g3 | Rat | furan | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | furan results in increased expression of CSNK1G3 mRNA | CTD | PMID:24183702 | Csnk1g3 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CSNK1G3 mRNA | CTD | PMID:22061828 | Csnk1g3 | Rat | leflunomide | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | leflunomide results in increased expression of CSNK1G3 mRNA | CTD | PMID:28988120 | Csnk1g3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | Csnk1g3 | Rat | ozone | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CSNK1G3 mRNA more ... | CTD | PMID:32699268 | Csnk1g3 | Rat | resveratrol | multiple interactions | ISO | CSNK1G3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1G3 mRNA | CTD | PMID:23557933 | Csnk1g3 | Rat | sodium fluoride | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of CSNK1G3 mRNA | CTD | PMID:21340527 | Csnk1g3 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA] | CTD | PMID:31150632 | Csnk1g3 | Rat | tetrachloromethane | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:31919559 | Csnk1g3 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CSNK1G3 mRNA | CTD | PMID:31150632 | Csnk1g3 | Rat | titanium dioxide | decreases methylation | ISO | Csnk1g3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CSNK1G3 gene and titanium dioxide results in decreased methylation of CSNK1G3 promoter | CTD | PMID:35295148 | Csnk1g3 | Rat | titanium dioxide | increases methylation | ISO | Csnk1g3 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CSNK1G3 gene | CTD | PMID:35295148 | Csnk1g3 | Rat | titanium dioxide | increases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CSNK1G3 mRNA | CTD | PMID:35295148 | Csnk1g3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | Csnk1g3 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of CSNK1G3 mRNA | CTD | PMID:25729387 | Csnk1g3 | Rat | troglitazone | decreases expression | ISO | Csnk1g3 (Mus musculus) | 6480464 | troglitazone results in decreased expression of CSNK1G3 mRNA | CTD | PMID:28973697 | Csnk1g3 | Rat | urethane | increases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Urethane results in increased expression of CSNK1G3 mRNA | CTD | PMID:28818685 | Csnk1g3 | Rat | valproic acid | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CSNK1G3 mRNA | CTD | PMID:23179753 | Csnk1g3 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of CSNK1G3 mRNA | CTD | PMID:19015723 | Csnk1g3 | Rat | vitamin E | decreases expression | ISO | CSNK1G3 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of CSNK1G3 mRNA | CTD | PMID:19244175 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
